Lijuan Gu Selected Research

Glucose (Dextrose)

9/2024	The action mechanism by which C1q/tumor necrosis factor-related protein-6 alleviates cerebral ischemia/reperfusion injury in diabetic mice.
9/2023	Neutral polysaccharide from Gastrodia elata alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis-mediated neuroinflammation via the NRF2/HO-1 signaling pathway.
1/2021	Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition.
7/2017	Effects of Passive Smoking on Glycemic Parameters and Lipid Profiles in a Chinese Female Population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijuan Gu Research Topics

Disease

17	Ischemic Stroke 05/2024 - 01/2019
17	Neoplasms (Cancer) 07/2023 - 12/2015
15	Brain Ischemia (Cerebral Ischemia) 09/2024 - 01/2016
14	Inflammation (Inflammations) 09/2024 - 01/2013
13	Stroke (Strokes) 05/2024 - 07/2012
9	Reperfusion Injury 09/2024 - 01/2016
6	Infarction (Infarctions) 01/2024 - 07/2012
5	Glioma (Gliomas) 07/2023 - 01/2017
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2022 - 05/2016
4	Carcinogenesis 01/2022 - 01/2019
4	Brain Injuries (Brain Injury) 01/2019 - 01/2016
3	Neuroinflammatory Diseases 09/2023 - 01/2016
3	Pathologic Processes 09/2023 - 12/2015
2	Hypoxia (Hypoxemia) 09/2024 - 01/2022
2	Brain Edema (Cerebral Edema) 05/2021 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2024
1	Type 2 Diabetes Mellitus (MODY) 05/2024
1	Embolic Stroke 05/2024
1	Central Nervous System Diseases (CNS Diseases) 12/2023
1	Leukemia 04/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Lung Injury 01/2022
1	Delirium 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 05/2021
1	Microsatellite Instability 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Edema (Dropsy) 10/2020
1	Brain Infarction 10/2020
1	Brain Death (Brain Dead) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2019

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2013
7	InflammasomesIBA 10/2023 - 01/2016
6	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2021
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2017
4	Oxygen (Dioxygen)IBA 09/2024 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 09/2024 - 07/2017
4	HMGB1 Protein (HMG1)IBA 09/2023 - 01/2013
4	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2017
3	Chimeric Antigen ReceptorsIBA 04/2023 - 01/2017
3	CytokinesIBA 10/2022 - 01/2021
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2021 - 12/2015
2	AntigensIBA 04/2023 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 01/2019
2	ChemokinesIBA 01/2022 - 01/2021
2	N-methylisoindigotinIBA 01/2021 - 01/2019
2	EnzymesIBA 01/2021 - 01/2019
2	Neuroprotective AgentsIBA 01/2021 - 10/2020
2	Ubiquitin-Specific ProteasesIBA 01/2019 - 12/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2024
1	Uric Acid (Urate)IBA 05/2024
1	CC ChemokinesIBA 12/2023
1	NucleotidesIBA 10/2023
1	NLR ProteinsIBA 10/2023
1	Interleukin-6 (Interleukin 6)IBA 09/2023
1	erastinIBA 09/2023
1	Polysaccharides (Glycans)IBA 09/2023
1	Epichlorohydrin (Epichlorhydrin)IBA 02/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2023
1	Small Interfering RNA (siRNA)IBA 12/2022
1	Malondialdehyde (Propanedial)IBA 12/2022
1	salicylhydroxamic acid (SHAM)IBA 10/2022
1	Antineoplastic Agents (Antineoplastics)IBA 10/2022
1	ApolipoproteinsIBA 09/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	CollagenIBA 01/2022
1	Collagen Type V (Type V Collagen)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 05/2021
1	Mitogen-Activated Protein KinasesIBA 05/2021
1	Pattern Recognition ReceptorsIBA 05/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	IgE Receptors (Fc epsilon RI)IBA 01/2021
1	Janus KinasesIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2021
1	tanshinone II A sodium sulfonateIBA 10/2020
1	3-methyladenineIBA 10/2020
1	TRPC6 Cation ChannelIBA 01/2020
1	ribonuclease T(2)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Ribonucleases (Ribonuclease)IBA 01/2020
1	Free RadicalsIBA 01/2020
1	Superoxides (Superoxide)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	Hydroxyl RadicalIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Receptor for Advanced Glycation End ProductsIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019

Therapy/Procedure

10	Therapeutics 04/2023 - 04/2014
6	Immunotherapy 07/2023 - 01/2017
2	Sutures (Suture) 02/2013 - 07/2012
1	Immunomodulation 05/2023
1	Fecal Microbiota Transplantation 10/2022
1	Photothermal Therapy 10/2022
1	Precision Medicine 10/2022
1	Drug Therapy (Chemotherapy) 01/2022